MDGL 8-K 2026-08-12

MADRIGAL PHARMACEUTICALS, INC. (MDGL) 8-K dated 2026-08-12 — accession 0001628280-26-055962. This URL is the filing, not the MDGL hub.

MADRIGAL PHARMACEUTICALS, INC. (MDGL) is a biotechnology company listed on NASDAQ.

MADRIGAL PHARMACEUTICALS, INC. filed a 8-K on 2026-08-12. Accession 0001628280-26-055962.

Cached items: 5.02, 7.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported MDGL revenue for 2025-12-31 was $958.4M. Net income was -$288.3M. Revenue was up 432.1% from 2024-12-31 to 2025-12-31. MDGL currently screens at market cap $11.56B.

Not investment advice. The MDGL SEC hub lists recent forms. The stock page is the research view.